TD-0212 is an orally active dual pharmacology antagonist of angiotensin II type 1 receptor (AT1) and inhibitor of neprilysin (NEP)(pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP).
TD-0212 TFA is an orally active dual pharmacology antagonist of angiotensin II type 1 receptor (AT1) and inhibitor of neprilysin (NEP)(pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP).
BWC0977 是一种有效的拓扑异构酶抑制剂,可通过同时靶向 DNA gyrase 和 topoisomerase IV 干扰细菌 DNA 复制。BWC0977 对多重耐药革兰氏阴性菌的最低抑菌浓度(MIC90)范围为 0.03–2 µg/mL。因此,BWC0977 被用于抗菌药理学研究,以研究革兰氏阴性菌模型系统中的双重拓扑异构酶抑制机制及耐药性特征。